Lidocaine Patch 5% — Class II drug recall D-1492-2020
Terminated recall by Teva Pharmaceuticals USA, reported 2020-08-19, distributed nationwide. Labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton
| Recall number | D-1492-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, Parsippany, NJ, United States |
| Recall initiated | 2020-07-14 |
| Classified | 2020-08-10 |
| Reported by FDA | 2020-08-19 |
| Terminated | 2021-07-07 |
| Distributed | Nationwide (US) |
| Quantity | 28,596 cartons |
| Reason classes | labeling |
| NDC | 00591-3525, 00591-3525-11, 00591-3525-30 |
| Lot numbers | 1383513, 1383513B |
| Expiration dates | 2022-03 |
Product
Lidocaine Patch 5%, packaged in 30-count cartons, Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA, NDC 0591-3525-30
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1492-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.